Correlation Between Virax Biolabs and Amylyx Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and Amylyx Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and Amylyx Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Virax Biolabs Group and Amylyx Pharmaceuticals, you can compare the effects of market volatilities on Virax Biolabs and Amylyx Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of Amylyx Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and Amylyx Pharmaceuticals.

Diversification Opportunities for Virax Biolabs and Amylyx Pharmaceuticals

-0.29

Correlation Coefficient

Virax Biolabs  Amylyx Pharmaceuticals

Very good diversification

The 3 months correlation between Virax and Amylyx is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and Amylyx Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amylyx Pharmaceuticals and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with Amylyx Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amylyx Pharmaceuticals has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and Amylyx Pharmaceuticals go up and down completely randomly.

Pair Corralation between Virax Biolabs and Amylyx Pharmaceuticals

Given the investment horizon of 90 days Virax Biolabs Group is expected to under-perform the Amylyx Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Virax Biolabs Group is 1.27 times less risky than Amylyx Pharmaceuticals. The stock trades about -0.04 of its potential returns per unit of risk. The Amylyx Pharmaceuticals is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest  515.00  in Amylyx Pharmaceuticals on May 5, 2025 and sell it today you would earn a total of  257.00  from holding Amylyx Pharmaceuticals or generate 49.9% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Virax Biolabs Group  vs.  Amylyx Pharmaceuticals

Virax Biolabs Group

Risk-Adjusted Performance

Very Weak

Over the last 90 days Virax Biolabs Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Amylyx Pharmaceuticals

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Amylyx Pharmaceuticals are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating essential indicators, Amylyx Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Virax Biolabs and Amylyx Pharmaceuticals

The main advantage of trading using opposite Virax Biolabs and Amylyx Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virax Biolabs position performs unexpectedly, Amylyx Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amylyx Pharmaceuticals will offset losses from the drop in Amylyx Pharmaceuticals' long position.

The idea behind Virax Biolabs Group and Amylyx Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.